Search research articles
Contact Us
Filters
Showing results (1021-1030 of 1,075) with videos related to
Page
of 108
Sort By:
The American Journal of Psychiatry
|
May 14, 2021
Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia
Yash B Joshi, Michael L Thomas, David L Braff, et al.
Schizophrenia Research
|
October 7, 2006
Successful multi-site measurement of antisaccade performance deficits in schizophrenia
Allen D Radant, Dorcas J Dobie, Monica E Calkins, et al.
Schizophrenia Bulletin
|
October 13, 2006
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration
Monica E Calkins, Dorcas J Dobie, Kristin S Cadenhead, et al.
Nature Medicine
|
February 12, 2019
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Archives of General Psychiatry
|
November 7, 2007
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia
Tiffany A Greenwood, David L Braff, Gregory A Light, et al.
Biological Psychiatry
|
August 15, 2008
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands
Bruce I Turetsky, Tiffany A Greenwood, Ann Olincy, et al.
Nature
|
December 4, 2009
Supernova 2007bi as a pair-instability explosion
A Gal-Yam, P Mazzali, E O Ofek, et al.
Schizophrenia Research
|
December 3, 2014
Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2
Gregory A Light, Neal R Swerdlow, Michael L Thomas, et al.
Nature Medicine
|
April 19, 2019
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Schizophrenia Research
|
December 16, 2014
California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS)
William S Stone, Raquelle I Mesholam-Gately, David L Braff, et al.
Page
of 108
Search research articles
Search
Showing results (1021-1030 of 1,075) with videos related to
Sort By:
Page
of 108
The American Journal of Psychiatry
|
May 14, 2021
Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia
Yash B Joshi, Michael L Thomas, David L Braff, et al.
Schizophrenia Research
|
October 7, 2006
Successful multi-site measurement of antisaccade performance deficits in schizophrenia
Allen D Radant, Dorcas J Dobie, Monica E Calkins, et al.
Schizophrenia Bulletin
|
October 13, 2006
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration
Monica E Calkins, Dorcas J Dobie, Kristin S Cadenhead, et al.
Nature Medicine
|
February 12, 2019
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Archives of General Psychiatry
|
November 7, 2007
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia
Tiffany A Greenwood, David L Braff, Gregory A Light, et al.
Biological Psychiatry
|
August 15, 2008
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands
Bruce I Turetsky, Tiffany A Greenwood, Ann Olincy, et al.
Nature
|
December 4, 2009
Supernova 2007bi as a pair-instability explosion
A Gal-Yam, P Mazzali, E O Ofek, et al.
Schizophrenia Research
|
December 3, 2014
Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2
Gregory A Light, Neal R Swerdlow, Michael L Thomas, et al.
Nature Medicine
|
April 19, 2019
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Schizophrenia Research
|
December 16, 2014
California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS)
William S Stone, Raquelle I Mesholam-Gately, David L Braff, et al.
Page
of 108